PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsTinea capitis
MeSH D014006 - tinea capitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D014005:Tinea
1 Company
1 Drug
$
Success rate
D012536:Scalp dermatoses
123 Companies
43 Drugs
$
Success rate
D014006: 
Tinea capitis
24 Companies
3 Drugs
$
Success rate
D014007:Tinea favosa
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaSelenium sulfide Selenium Sulfide  1982-01-01   
PadagisSelenium sulfide Selenium Sulfide  1991-01-10   
Taro PharmaceuticalTerbinafine Terbinafine  2007-07-02   
Glenmark PharmaceuticalsTerbinafine Terbinafine  2007-07-02   
MylanTerbinafine Terbinafine  2007-07-02   
NATCO PharmaTerbinafine Terbinafine  2007-07-02   
GSKTerbinafine Lamisil  1997-10-17   
Terbinafine Lamisil At  2000-03-17   
CiplaTerbinafine Terbinafine  2007-07-02   
Griseofulvin Griseofulvin  2007-09-10   
NovartisTerbinafine Lamisil  1992-12-30   
SanofiSelenium sulfide Selsun  1982-01-01   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
50%
1/2
Phase 3
71%
5/7
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
Terbinafine
GSK
Terbinafine
Novartis
Terbinafine,
Tdt067
Allergan
Griseofulvin
Dr Reddys Laboratories
Terbinafine
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use